The urgency of this argument is sharpened when placed against recent disruptions. The COVID-19 pandemic did not create Nigeria’s pharmaceutical vulnerabilities; it revealed them in real...
FG’s 2026 policy reduces import duties on pharmaceuticals, rice, and cars. Stakeholders react as benefits and risks emerge across sectors.
Looking forward, the next competitive advantage in Nigeria’s pharmaceutical industry will not be built on products alone, but on narrative. Leaders must ensure that what is...